Table 2.
Regression analysis between the ratio of MG-II 16S rRNA genes to Archaeal 16S rRNA genes vs. the fractional abundance of GDGTs, ring index (RI2), and the ratio of GDGT-2 to GDGT-3.
| [MG-II/Archaea] vs. CLa | [MG-II/Archaea] vs. total-IPL | [MG-II/Archaea] vs. phospho-IPL | ||||
|---|---|---|---|---|---|---|
| R2 | P-value | R2 | P-value | R2 | P-value | |
| %GDGT-0 | 0.37 | 0.04 | 0.44 | 0.02 | 0.40 | 0.03 |
| %GDGT-1 | 0.50 | 0.01 | 0.58 | 0.00 | 0.72 | 0.00 |
| %GDGT-2 | 0.43 | 0.02 | 0.47 | 0.01 | 0.60 | 0.00 |
| %GDGT-3 | 0.33 | 0.05 | 0.51 | 0.01 | 0.69 | 0.00 |
| %GDGT-4 | 0.43 | 0.02 | 0.46 | 0.02 | 0.58 | 0.00 |
| %Cren. | 0.25 | 0.10 | 0.37 | 0.03 | 0.21 | 0.13 |
| %Cren.iso | 0.56 | 0.01 | 0.11 | 0.80 | 0.53 | 0.01 |
| RI2 | 0.49 | 0.01 | 0.50 | 0.01 | 0.72 | 0.00 |
| GDGT 2/3 | 0.13 | 0.25 | 0.30 | 0.07 | 0.11 | 0.29 |
[MG-II/Archaea], the 16S rRNA gene ratio of MG-II to archaeal. CL, core lipids; total-IPL, intact polar lipids derived upon acid hydrolysis; phospho-IPL, intact polar lipids derived upon base hydrolysis.